Jitanaporn Wattanathorn
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
NCT Number: NCT02562274
This study the investigators aimed to determine the effect of the herbal porridge containing the combined extract of mulberry and Vietnamese coriander (MP) on cognitive function and bone formation markers of menopausal women. Forty-five participants were randomly assigned to receive a placebo or MP (50, 1500 mg) treatments once daily for 8 weeks.
Looking for future studies?
Notify Me45 year–60 year
Female
Interventional
Phase 1
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
At present, the novel cheap and effective intervention against menopause related symptoms such as memory impairment and osteoporosis is still required due to the increased breast cancer risk induced by hormone replacement therapy. Based on the role of oxidative stress on cognitive deficit in menopause and the synergistic effect of herbs in traditional folklore, the cognitive enhancing effects and anti-osteoporosis effects of the functional food containing the combined extract of herbs possessing antioxidant effect has gained attention. Therefore, we aimed to determine the effect of the herbal porridge containing the combined extract of mulberry and Vietnamese coriander (MP) on cognitive function and bone formation markers of menopausal women. Forty-five participants were randomly assigned to receive a placebo or MP (50, 1500 mg) treatments once daily for 8 weeks. The cognitive function and working memory were assessed via the auditory oddball paradigm of event-related potentials and computerized battery tests respectively prior to the intervention, 1 month, 2 month, and at delay 1 month. Bone formation markers including serum calcium, alkaline phosphatase, and osteocalcin were determine prior to the intervention and at the end of study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects are received placebo treatments once daily for 8 weeks
Subjects are received MP 50 mg/day treatments once daily for 8 weeks
Subjects are received MP 1500 mg/day treatments once daily for 8 weeks
Time frame: 3 months
Time frame: 3 months
Time frame: 2 months
Time frame: 2 months
Time frame: 3 months
Time frame: 3 months
Khon Kaen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05292378
Cognition Disorders, Cognitive Dysfunction
Piscataway, New Jersey, United States
View Trial DetailsNCT06318390
Cardiovascular Diseases, Cognition Disorders
Arlington, Texas, United States
View Trial DetailsNCT06318377
Cardiovascular Diseases, Cognition Disorders
Arlington, Texas, United States
View Trial DetailsNCT04277104
Alzheimer Disease, Brain Diseases
Bern, Switzerland
View Trial Details